Technology News and Research

RSS

Immunologix partners with Genscript to develop human antibody therapeutics

Immunologix, Inc, a Charleston, SC biotechnology company and a leader in fully human therapeutic antibodies for a variety of diseases and GenScript, a contract research organization (CRO) based in Piscataway, NJ and the industry leader in bio-reagent services, assay development & screening, lead optimization, and antibody drug development, announced today that the companies have formed a strategic partnership to offer a complete platform for producing human antibody therapeutics.

10 Nov 2010

Only one-third of young women complete HPV regimen

Despite strong evidence of its effectiveness, few of the young women who are eligible for the human papillomavirus (HPV) vaccine take it, according to research presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10.

10 Nov 2010

Senior Scientific receives QTDP grants for cancer detection and treatment

Manhattan Scientifics, Inc. (OTCBB: MHTX) announced that Senior Scientific LLC is the recipient of four grants totaling $702,899 awarded by the Qualifying Therapeutic Discovery Grant Program.

10 Nov 2010

Iris BioTechnologies awarded $245,000 grant under QTDP Program

Iris BioTechnologies Inc., a life sciences company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, and recipient of the Frost and Sullivan 2008 Technology Innovation Award in Pharmacogenomics, is pleased to announce that the company has been awarded $245,000, the maximum amount given for a grant under the US Qualifying Therapeutic Discovery Project (QTDP) Program.

10 Nov 2010

Undergraduate students win Gates Foundation grant for low-cost ultrasound system

A team of University of Washington undergraduate students was among 65 research groups that today learned they had won one of the Bill & Melinda Gates Foundation's $100,000 Grand Challenges Explorations grants.

10 Nov 2010

MicroAire and Arthrex enter agreement to settle ECTR patent infringement suit

MicroAire Surgical Instruments LLC and Arthrex Inc. announced today that they have entered an agreement to settle a suit accusing Arthrex of patent infringement and breach of contract. At issue was the patented technology that MicroAire owns for minimally invasive treatment of Carpal Tunnel Syndrome.

10 Nov 2010

Biovista and Pfizer enter pilot research collaboration

Biovista announced today that it has entered into a pilot research collaboration agreement with Pfizer. The aim of the collaboration is to identify new indications for a number of undisclosed Pfizer development candidates, using Biovista's Clinical Outcome Search Space (COSS) technology.

10 Nov 2010

Boston Scientific announces first implantation of Vercise Deep Brain Stimulation System in Parkinson's disease trial

Boston Scientific Corporation today announced the first implantation of its Vercise™ Deep Brain Stimulation (DBS) System as part of the VANTAGE clinical trial. VANTAGE is a multi-center, prospective trial designed to examine the improvement of motor function in approximately 40 European patients implanted with the Vercise DBS System for the treatment of Parkinson's disease.

10 Nov 2010

CRi adds TRIO to Nuance multispectral imaging product family

Cambridge Research & Instrumentation, Inc. (CRi), a leader in multicolor imaging solutions for preclinical and clinical research, today announced the newest addition to the award-winning Nuance™ multispectral imaging product family for multicolor tissue and cell-based imaging. The TRIO system is compact, multipurpose and affordable, offering a simplified interface and versatile design to fit any microscope with a camera-mount.

10 Nov 2010

Gov't health IT spending attracts investments from all over

As part of its foray into health IT, AT&T has partnered with WellDoc, a Baltimore-based company that makes an FDA-approved mobile-phone application to help manage diabetes, The Baltimore Sun reports. "The telecommunications giant launched a new business segment last week that will focus on technology solutions for the health care industry. And WellDoc's software will be pitched by AT&T's huge marketing muscle to commercial clients ranging from hospitals to insurers to employers" (Sentementes, 11/8).

10 Nov 2010

Baxa launches ExactaMix 1200 Automated Compounding Device

Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations, today introduced the ExactaMix 1200 Automated Compounding Device (ACD) for small- to mid-sized hospital pharmacies in need of an automated approach to compounding large-volume parenteral doses.

9 Nov 2010

Health advice on NHS website saves £44 million per year

The latest study has shown that as more people self diagnose using the NHS Choices website, Britain’s national healthcare service saves millions of pounds every year. The website was launched three years ago. Last year more than 100 million visits were recorded at the site which offers patients a quick reference guide to illnesses, symptoms, diagnosis and treatment. Overall, there was a 10% increase in the number of visits to the website in 2010 compared to 2009. Some 19 million people logged on to NHS Choices for information on swine flu.

9 Nov 2010

Hypernetworking and hypertexting bad for kids in more ways than one: Study

According to a new study adolescents who text excessively or who are hooked on social networking sites are more likely to engage in unhealthy behaviors like smoking and binge drinking than their peers who are not similar users. Scientists at the Case Western Reserve School of Medicine surveyed 4,257 high school students from an urban county in the Midwest to look at the health effects of communications technology usage.

9 Nov 2010

ArQule reduces third quarter net loss to $6,394,000

ArQule, Inc. today reported its results of operations for the fiscal quarter and nine months ended September 30, 2010.

9 Nov 2010

Redpoint Bio decreases third quarter net loss to $1.8 million

Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced financial and operational results for the three months and nine months ended September 30, 2010.

9 Nov 2010

First Edition: November 9, 2010

Today's news includes reports about the Supreme Court's decision regarding an early challenge to the health law.

9 Nov 2010

Excessive texting and networking raise new health concerns for teens

Texting while driving can be a deadly combination for teenagers. Yet, new data released today reveal that the dangers of excessive texting among teens are not limited to the road. Hyper-texting and hyper-networking are now giving rise to a new health risk category for this age group.

9 Nov 2010

Discovery Labs reports net operating loss of $6.2 million for third quarter 2010

Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and a financial update for the third quarter ended September 30, 2010.

9 Nov 2010

Spectral Molecular Imaging awarded $190,172 QTDP grant for development of melanoma detection system

Cascade Technologies Corp., announced today that its wholly-owned subsidiary Spectral Molecular Imaging, Inc. (SMI) has received a grant under the Qualifying Therapeutic Discovery Project (QTDP) program to advance the development of the company's SkinSpect system for the detection of melanoma and other skin cancers.

9 Nov 2010

Research report on current and evolving technologies in drug delivery

The drug delivery market is a rapidly evolving force in the pharmaceutical industry. Within this segment injectables have a significant role to play at present with the increasing use of proteins and peptides.

9 Nov 2010